Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Joanna Ellis and Maria Zambon.
Connection Strength

2.941
  1. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 02; 26(5).
    View in: PubMed
    Score: 0.232
  2. Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020. Lancet Reg Health Eur. 2021 Apr; 3:100038.
    View in: PubMed
    Score: 0.231
  3. High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19: Prospective cohort study, England. EClinicalMedicine. 2020 Nov; 28:100597.
    View in: PubMed
    Score: 0.228
  4. Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020. EClinicalMedicine. 2020 Sep; 26:100533.
    View in: PubMed
    Score: 0.225
  5. Probable Vertical Transmission of SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020 09; 39(9):e257-e260.
    View in: PubMed
    Score: 0.225
  6. Viral Shedding in Recipients of Live Attenuated Influenza Vaccine in the 2016-2017 and 2017-2018 Influenza Seasons in the United Kingdom. Clin Infect Dis. 2020 06 10; 70(12):2505-2513.
    View in: PubMed
    Score: 0.222
  7. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18. Euro Surveill. 2019 Aug; 24(31).
    View in: PubMed
    Score: 0.209
  8. Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17. Euro Surveill. 2018 09; 23(39).
    View in: PubMed
    Score: 0.196
  9. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16. Euro Surveill. 2018 06; 23(25).
    View in: PubMed
    Score: 0.193
  10. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. Euro Surveill. 2017 Nov; 22(44).
    View in: PubMed
    Score: 0.185
  11. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect. 2021 11; 83(5):573-580.
    View in: PubMed
    Score: 0.060
  12. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020. EClinicalMedicine. 2021 Jul; 37:100948.
    View in: PubMed
    Score: 0.059
  13. The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system. Euro Surveill. 2021 03; 26(11).
    View in: PubMed
    Score: 0.058
  14. Cross sectional investigation of a COVID-19 outbreak at a London Army barracks: Neutralising antibodies and virus isolation. Lancet Reg Health Eur. 2021 Mar; 2:100015.
    View in: PubMed
    Score: 0.058
  15. Rapid community point-of-care testing for COVID-19 (RAPTOR-C19): protocol for a platform diagnostic study. Diagn Progn Res. 2021 Feb 08; 5(1):4.
    View in: PubMed
    Score: 0.058
  16. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England. Br J Gen Pract. 2020 12; 70(701):e890-e898.
    View in: PubMed
    Score: 0.057
  17. Do point-of-care tests (POCTs) offer a new paradigm for the management of patients with influenza? Euro Surveill. 2020 11; 25(44).
    View in: PubMed
    Score: 0.057
  18. Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020. Euro Surveill. 2020 08; 25(32).
    View in: PubMed
    Score: 0.056
  19. Increased risk of SARS-CoV-2 infection in staff working across different care homes: enhanced CoVID-19 outbreak investigations in London care Homes. J Infect. 2020 Oct; 81(4):621-624.
    View in: PubMed
    Score: 0.056
  20. Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein. Genome Med. 2020 07 28; 12(1):68.
    View in: PubMed
    Score: 0.056
  21. Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England. J Infect. 2020 Sep; 81(3):427-434.
    View in: PubMed
    Score: 0.056
  22. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020 09; 20(9):1034-1042.
    View in: PubMed
    Score: 0.055
  23. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. JMIR Public Health Surveill. 2020 04 02; 6(2):e18606.
    View in: PubMed
    Score: 0.055
  24. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 01; 25(3).
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.